Literature DB >> 9151142

Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles.

W G Jiang1, S Hiscox.   

Abstract

Hepatocyte growth factor (HGF), otherwise known as scatter factor (SF), is a recently identified cytokine which exerts a wide spectrum of biological functions on a variety of cell types. Its receptor is encoded by the c-met proto-oncogene. HGF/SF has been implicated in the regulation of mitogenesis, motogenesis, and morphogenesis. Over the past few years, the structure, function and signal transduction pathways of HGF/SF and its receptor have become clearer. The cytokine is now known to play important roles in the regulation of both normal physiological processes as well as pathological ones. This review summarises recent progress involving HGF/SF and its receptor and discusses their role in cell biology, organ regeneration, cancer and other processes. Hepatocyte growth factor (HGF) is a pleiotropic growth factor originally identified as a potent mitogen agent for rat hepatocytes. Subsequent studies have shown that it is mitogenic for a wide range of epithelial cells and not limited to hepatocytes. Its behaviour as a motogenic stimulator promoted its independent discovery and naming of scatter factor (SF). Analysis of cDNA and amino acid sequences have revealed that the two molecules are the same. A number of cytokine agents are known to stimulate cellular motility, however, it is the function of HGF/SF as a potent motogenic, mitogenic and morpho-regulatory agent on the diverse variety of cell types that makes the discovery of HGF/SF factor one of the most interesting stories in terms of identification of novel cytokines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151142

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  15 in total

Review 1.  Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.

Authors:  Alessia Locatelli; Kristopher A Lofgren; Andrea R Daniel; Nancy E Castro; Carol A Lange
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

2.  Healing of leg ulcers associated with transjugular intrahepatic portosystemic shunt in decompensated cirrhosis: case series of a possible hepatodermal syndrome.

Authors:  Cherif M El Younis; Nora V Bergasa
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-03

3.  Met receptors induce Sam68-dependent cell migration by activation of alternate extracellular signal-regulated kinase family members.

Authors:  Alessia Locatelli; Carol A Lange
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

4.  Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide.

Authors:  J E Cartwright; D P Holden; G S Whitley
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

5.  Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.

Authors:  M Oberst; J Anders; B Xie; B Singh; M Ossandon; M Johnson; R B Dickson; C Y Lin
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

6.  Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy.

Authors:  Xiaodan Ren; Cory Hogaboam; Audra Carpenter; Lisa Colletti
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 7.  Multisciplinary management of patients with liver metastasis from colorectal cancer.

Authors:  Kathleen De Greef; Christian Rolfo; Antonio Russo; Thiery Chapelle; Giuseppe Bronte; Francesco Passiglia; Andreia Coelho; Konstantinos Papadimitriou; Marc Peeters
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

8.  Effects of sequential injections of hepatocyte growth factor and insulin-like growth factor-I on adult rabbit extraocular muscle.

Authors:  Christy L Willoughby; Steven Ralles; Stephen P Christiansen; Linda K McLoon
Journal:  J AAPOS       Date:  2012-08       Impact factor: 1.220

9.  Late intervention with the small molecule BB3 mitigates postischemic kidney injury.

Authors:  Prakash Narayan; Bin Duan; Kai Jiang; Jingsong Li; Latha Paka; Michael A Yamin; Scott L Friedman; Matthew R Weir; Itzhak D Goldberg
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-01

10.  Hepatocyte growth factor increases osteopontin expression in human osteoblasts through PI3K, Akt, c-Src, and AP-1 signaling pathway.

Authors:  Hsien-Te Chen; Hsi-Kai Tsou; Chia-Hao Chang; Chih-Hsin Tang
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.